From NewAtlas.com….
The first participants have been dosed in a large Phase 2/3 trial testing a novel oral treatment designed to alleviate symptoms of COVID-19. The first results are expected by the end of this year.
A simple, pill-based COVID-19 treatment that can be taken at home during the earliest stages of infection is perhaps the biggest missing link in the fight against SARS-CoV-2. Over the past 18 months an incredible array of treatments have been developed, from prophylactic vaccines to monoclonal antibodies preventing serious disease.
But while vaccines can help reduce a person’s risk of hospitalization or death, and other therapies can be administered while in hospital to prevent serious decline, there is a vital need for an effective oral treatment that can be taken at home in the very earliest stages of disease.
A number of anti-COVID-19 pills are currently in development, but Pfizer’s candidate is one of the first oral antivirals designed specifically to target SARS-CoV-2 to reach advanced human trial stages.
